Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Liégeois J[au]:

Search results

Items: 1 to 50 of 82

1.

Sight or smell: which senses do scavenging raptors use to find food?

Potier S, Duriez O, Célérier A, Liegeois JL, Bonadonna F.

Anim Cogn. 2019 Jan;22(1):49-59. doi: 10.1007/s10071-018-1220-0. Epub 2018 Oct 26.

2.

Structural Insights into 5-HT1A/D4 Selectivity of WAY-100635 Analogues: Molecular Modeling, Synthesis, and in Vitro Binding.

Dilly S, Liégeois JF.

J Chem Inf Model. 2016 Jul 25;56(7):1324-31. doi: 10.1021/acs.jcim.5b00753. Epub 2016 Jul 13.

PMID:
27331407
3.

Chemical modifications of the N-methyl-laudanosine scaffold point to new directions for SK channels exploration.

Badarau E, Dilly S, Wouters J, Seutin V, Liégeois JF.

Bioorg Med Chem Lett. 2014 Dec 15;24(24):5616-5620. doi: 10.1016/j.bmcl.2014.10.083. Epub 2014 Nov 6.

PMID:
25466186
4.

Enhancing a CH-π Interaction to Increase the Affinity for 5-HT1A Receptors.

Liégeois JF, Lespagnard M, Meneses Salas E, Mangin F, Scuvée-Moreau J, Dilly S.

ACS Med Chem Lett. 2014 Jan 29;5(4):358-62. doi: 10.1021/ml4004843. eCollection 2014 Apr 10.

5.

Bis-(1,2,3,4-tetrahydroisoquinolinium): a chiral scaffold for developing high-affinity ligands for SK channels.

Liégeois JF, Wouters J, Seutin V, Dilly S.

ChemMedChem. 2014 Apr;9(4):737-40.

PMID:
24829978
6.

Cluster of atherosclerosis in a captive population of black kites (Milvus migrans subsp.) in France and effect of nutrition on the plasma lipid profile.

Facon C, Beaufrere H, Gaborit C, Albaric O, Plassiart G, Ammersbach M, Liegeois JL.

Avian Dis. 2014 Mar;58(1):176-82.

PMID:
24758133
7.

The interactions of apamin and tetraethylammonium are differentially affected by single mutations in the pore mouth of small conductance calcium-activated potassium (SK) channels.

Dilly S, Philippart F, Lamy C, Poncin S, Snyders D, Seutin V, Liégeois JF.

Biochem Pharmacol. 2013 Feb 15;85(4):560-9. doi: 10.1016/j.bcp.2012.12.015. Epub 2012 Dec 24.

PMID:
23270990
8.

Implementation of a design space approach for enantiomeric separations in polar organic solvent chromatography.

Nistor I, Lebrun P, Ceccato A, Lecomte F, Slama I, Oprean R, Badarau E, Dufour F, Dossou KS, Fillet M, Liégeois JF, Hubert P, Rozet E.

J Pharm Biomed Anal. 2013 Feb 23;74:273-83. doi: 10.1016/j.jpba.2012.10.015. Epub 2012 Nov 2.

PMID:
23245261
9.

Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.

Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4550-4. doi: 10.1016/j.bmcl.2012.05.119. Epub 2012 Jun 7.

PMID:
22738628
10.

[Physiology, pharmacology and modelling of potassium channels: focus on SK channels].

Dilly S, Poncin S, Lamy C, Liégeois JF, Seutin V.

Med Sci (Paris). 2012 Apr;28(4):395-402. doi: 10.1051/medsci/2012284017. Epub 2012 Apr 25. Review. French.

11.

New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.

Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI.

J Med Chem. 2012 Feb 23;55(4):1572-82. doi: 10.1021/jm2013419. Epub 2012 Feb 13.

PMID:
22268448
12.

Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channels.

Weatherall KL, Seutin V, Liégeois JF, Marrion NV.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18494-9. doi: 10.1073/pnas.1110724108. Epub 2011 Oct 24.

13.

Synthesis and radioligand binding studies of bis-(8-isopropyl-isoquinolinium) derivatives as ligands for apamin-sensitive sites on cloned SK2 and SK3 channels.

Badarau E, Dilly S, Dufour F, Poncin S, Seutin V, Liégeois JF.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6756-9. doi: 10.1016/j.bmcl.2011.09.043. Epub 2011 Sep 16.

PMID:
21978678
14.

The 5-HT(1A) agonism potential of substituted piperazine-ethyl-amide derivatives is conserved in the hexyl homologues: molecular modeling and pharmacological evaluation.

Dilly S, Scuvée-Moreau J, Wouters J, Liégeois JF.

J Chem Inf Model. 2011 Nov 28;51(11):2961-6. doi: 10.1021/ci200313r. Epub 2011 Oct 10.

PMID:
21957888
15.

Ion-channel modulators: more diversity than previously thought.

Dilly S, Lamy C, Marrion NV, Liégeois JF, Seutin V.

Chembiochem. 2011 Aug 16;12(12):1808-12. doi: 10.1002/cbic.201100236. Epub 2011 Jul 1. Review.

PMID:
21726033
16.

Interaction of clozapine and its nitrenium ion with rat D2 dopamine receptors: in vitro binding and computational study.

Dilly S, Liégeois JF.

J Comput Aided Mol Des. 2011 Feb;25(2):163-9. doi: 10.1007/s10822-010-9407-8. Epub 2010 Dec 24.

PMID:
21184252
17.
18.

Allosteric block of KCa2 channels by apamin.

Lamy C, Goodchild SJ, Weatherall KL, Jane DE, Liégeois JF, Seutin V, Marrion NV.

J Biol Chem. 2010 Aug 27;285(35):27067-77. doi: 10.1074/jbc.M110.110072. Epub 2010 Jun 18.

19.

The sigma agonist 1,3-di-o-tolyl-guanidine directly blocks SK channels in dopaminergic neurons and in cell lines.

Lamy C, Scuvée-Moreau J, Dilly S, Liégeois JF, Seutin V.

Eur J Pharmacol. 2010 Sep 1;641(1):23-8. doi: 10.1016/j.ejphar.2010.05.008. Epub 2010 May 26.

PMID:
20546722
20.

Bis-tetrahydroisoquinoline derivatives: structure analysis of the three stereoisomers of 1,1'-(propane-1,3-diyl)-bis-(6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline).

Wouters J, Elasaad K, Norberg B, Graulich A, Liégeois JF.

Eur J Med Chem. 2010 Jul;45(7):3240-4. doi: 10.1016/j.ejmech.2010.03.020. Epub 2010 Mar 25.

PMID:
20381214
21.

M-type channels selectively control bursting in rat dopaminergic neurons.

Drion G, Bonjean M, Waroux O, Scuvée-Moreau J, Liégeois JF, Sejnowski TJ, Sepulchre R, Seutin V.

Eur J Neurosci. 2010 Mar;31(5):827-35. doi: 10.1111/j.1460-9568.2010.07107.x.

22.

Molecular modeling study of 4-phenylpiperazine and 4-phenyl-1,2,3,6-tetrahydropyridine derivatives: a new step towards the design of high-affinity 5-HT1A ligands.

Dilly S, Graulich A, Liégeois JF.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1118-23. doi: 10.1016/j.bmcl.2009.12.027. Epub 2009 Dec 6.

PMID:
20022748
23.

SK channel blockade promotes burst firing in dorsal raphe serotonergic neurons.

Rouchet N, Waroux O, Lamy C, Massotte L, Scuvée-Moreau J, Liégeois JF, Seutin V.

Eur J Neurosci. 2008 Sep;28(6):1108-15. doi: 10.1111/j.1460-9568.2008.06430.x. Epub 2008 Sep 9.

PMID:
18783364
24.

Bis-tetrahydroisoquinoline derivatives: AG525E1, a new step in the search for non-quaternary non-peptidic small conductance Ca(2+)-activated K(+) channel blockers.

Graulich A, Lamy C, Alleva L, Dilly S, Chavatte P, Wouters J, Seutin V, Liégeois JF.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3440-5. doi: 10.1016/j.bmcl.2008.03.069. Epub 2008 Mar 29. Erratum in: Bioorg Med Chem Lett. 2010 Jan 1;20(1):422.

PMID:
18436444
25.

Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.

Tarazi FI, Moran-Gates T, Gardner MP, Graulich A, Lamy C, Liégeois JF.

J Mol Neurosci. 2007;32(3):192-8.

PMID:
17873364
26.

Synthesis and radioligand binding studies of bis-isoquinolinium derivatives as small conductance Ca(2+)-activated K(+) channel blockers.

Graulich A, Dilly S, Farce A, Scuvée-Moreau J, Waroux O, Lamy C, Chavatte P, Seutin V, Liégeois JF.

J Med Chem. 2007 Oct 18;50(21):5070-5. Epub 2007 Sep 15.

PMID:
17867663
27.

Metaplastic effect of apamin on LTP and paired-pulse facilitation.

Ris L, Capron B, Sclavons C, Liégeois JF, Seutin V, Godaux E.

Learn Mem. 2007 Jun 5;14(6):390-9. Print 2007 Jun.

28.

SK channels are on the move.

Seutin V, Liégeois JF.

Br J Pharmacol. 2007 Jul;151(5):568-70. Epub 2007 May 8.

30.
31.

Synthesis and radioligand binding studies of methoxylated 1,2,3,4-tetrahydroisoquinolinium derivatives as ligands of the apamin-sensitive Ca2+-activated K+ channels.

Graulich A, Scuvée-Moreau J, Alleva L, Lamy C, Waroux O, Seutin V, Liégeois JF.

J Med Chem. 2006 Nov 30;49(24):7208-14.

PMID:
17125273
32.

Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.

Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.

J Neurosci Res. 2006 Aug 15;84(3):675-82.

PMID:
16810690
33.

Identification of a pharmacophore of SKCa channel blockers.

Dilly S, Graulich A, Farce A, Seutin V, Liegeois JF, Chavatte P.

J Enzyme Inhib Med Chem. 2005 Dec;20(6):517-23.

PMID:
16408787
34.

SK channels control the firing pattern of midbrain dopaminergic neurons in vivo.

Waroux O, Massotte L, Alleva L, Graulich A, Thomas E, Liégeois JF, Scuvée-Moreau J, Seutin V.

Eur J Neurosci. 2005 Dec;22(12):3111-21.

PMID:
16367777
36.

Synthesis and biological evaluation of N-methyl-laudanosine iodide analogues as potential SK channel blockers.

Graulich A, Mercier F, Scuvée-Moreau J, Seutin V, Liégeois JF.

Bioorg Med Chem. 2005 Feb 15;13(4):1201-9.

PMID:
15670929
37.

Electrophysiological characterization of the SK channel blockers methyl-laudanosine and methyl-noscapine in cell lines and rat brain slices.

Scuvée-Moreau J, Boland A, Graulich A, Van Overmeire L, D'hoedt D, Graulich-Lorge F, Thomas E, Abras A, Stocker M, Liégeois JF, Seutin V.

Br J Pharmacol. 2004 Nov;143(6):753-64. Epub 2004 Oct 25.

38.

Development and validation of a high-performance liquid chromatographic method for the determination of cyproterone acetate in human skin.

Henry de Hassonville S, Chiap P, Liégeois JF, Evrard B, Delattre L, Crommen J, Piel G, Hubert P.

J Pharm Biomed Anal. 2004 Sep 21;36(1):133-43.

PMID:
15351057
39.

Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry.

Liégeois JF, Mercier F, Graulich A, Graulich-Lorge F, Scuvée-Moreau J, Seutin V.

Curr Med Chem. 2003 Apr;10(8):625-47. Review.

PMID:
12678783
40.

JL 13, an atypical antipsychotic: a preclinical review.

Ellenbroek BA, Liégeois JF.

CNS Drug Rev. 2003 Spring;9(1):41-56. Review.

41.

[Orthopedic immobilization].

Schuind F, Moulart F, Liegeois JM, Dejaie L, Strens C, Burny F.

Acta Orthop Belg. 2002 Dec;68(5):439-61. Review. French.

PMID:
12584974
42.

New pyridobenzodiazepine derivatives: modifications of the basic side chain differentially modulate binding to dopamine (D(4.2), D(2L)) and serotonin (5-HT(2A)) receptors.

Liégeois JF, Eyrolles L, Ellenbroek BA, Lejeune C, Carato P, Bruhwyler J, Géczy J, Damas J, Delarge J.

J Med Chem. 2002 Nov 7;45(23):5136-49.

PMID:
12408724
43.

Methyl-laudanosine: a new pharmacological tool to investigate the function of small-conductance Ca(2+)-activated K(+) channels.

Scuvee-Moreau J, Liegeois JF, Massotte L, Seutin V.

J Pharmacol Exp Ther. 2002 Sep;302(3):1176-83.

PMID:
12183678
45.

[Control of cutaneous blood vessels].

Damas J, Garbacki N, Liégeois JF, Juchmes J.

Rev Med Liege. 2001 Dec;56(12):846-9. Review. French.

46.

Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.

Liégeois JF, Bruhwyler J, Hendrick JC, Delarge J, Legros JJ, Damas J.

Neurosci Lett. 2002 Feb 8;319(1):49-52.

PMID:
11814651
47.

The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primates.

Casey DE, Bruhwyler J, Delarge J, Géczy J, Liégeois JF.

Psychopharmacology (Berl). 2001 Sep;157(3):228-35.

PMID:
11605077
48.

Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives.

Rogister F, Laeckmann D, Plasman P, Van Eylen F, Ghyoot M, Maggetto C, Liégeois J, Géczy J, Herchuelz A, Delarge J, Masereel B.

Eur J Med Chem. 2001 Jul-Aug;36(7-8):597-614.

PMID:
11600230
49.

Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia.

Ellenbroek BA, Liégeois JF, Bruhwyler J, Cools AR.

J Pharmacol Exp Ther. 2001 Jul;298(1):386-91.

PMID:
11408566
50.

Electrooxidation potential as a tool in the early screening for new safer clozapine-like analogues.

Mouithys-Mickalad A, Kauffmann JM, Petit C, Bruhwyler J, Liao Y, Wikström H, Damas J, Delarge J, Deby-Dupont G, Géczy J, Liégeois JF.

J Med Chem. 2001 Mar 1;44(5):769-76.

PMID:
11262087

Supplemental Content

Loading ...
Support Center